New research suggests the best diet for improving cardiometabolic advantages and lowering risk of heart attack.


HEART attacks happens when a blockage in your coronary artery causes part of your heart muscle to be starved of blood and oxygen and this process is the result of poor lifestyle decisions taken over time. A new study has found how a certain diet impacts ghrelin levels and belly fat which equally impacts heart attack risk. According to the study, what is the best diet to help significantly reduce your risk?

Heart attack risk is largely influenced by the lifestyle choices and diet being key factors. While poor dietary decisions can hike your risk of developing the deadly complication, opting for healthy equivalents can help to ward off the threat. A new study has found one of the best diets to help improve cardiometabolic benefits reducing heart attack risk.

Fasting levels of the “hunger hormone” ghrelin rebound after weight loss significantly reduces belly fat and helps to improve the body’s sensitivity to insulin.

This action could also help to lower a person’s risk of having a heart attack according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Ghrelin is a stomach-derived hormone that stimulates appetite with levels rising during overnight fasting when a person is sleeping.

The 18m clinical trial study found that individuals who have higher levels of fasting ghrelin face decreased risk of developing diabetes and other metabolic diseases.

Research has previously shown that eating a Mediterranean-style diet can reduce your risk of another heart attack.

The study delved further on these findings and found that individuals who followed the green-Mediterranean diet had two-fold greater elevation in fasting ghrelin levels further improving cardiometabolic benefits.

A green-Mediterranean diet (green-MED) includes leafy vegetable called Mankai and green tea and omitted red meat consumption.

“The findings suggest fasting ghrelin levels may serve as a valuable indicator of cardiometabolic health following weight loss,” said the study’s senior author, Iris Shai of Ben-Gurion University of the Negev in Beer-Sheva, Israel, and the Harvard T.H. Chan School of Public Health in Boston, Mass.


Shai and colleagues examined fasting ghrelin levels in 294 participants over 18 months.

During the trial, participants with either abdominal obesity or dyslipidaemia—a condition with abnormally elevated cholesterol or fats in the blood—were randomised to one of three diets: following healthy dietary guidelines, the Mediterranean diet or a green version of the Mediterranean. “Brinkwire Summary News”.


Comments are closed.